S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

MediPharm Labs Corp. (LABS.TO) Stock Forecast, Price & News

-0.01 (-2.02 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: C$0.49
50-Day Range
MA: C$0.72
52-Week Range
Now: C$0.49
Volume2.78 million shs
Average Volume2.96 million shs
Market CapitalizationC$67.70 million
P/E RatioN/A
Dividend YieldN/A
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to licensed cultivators in Canada. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.


IIROC Trade Resumption - LABS
March 2, 2021 |  finance.yahoo.com
Canntab Begins Delivery of Tablets to MediPharm
December 1, 2020 |  prnewswire.com
MediPharm Labs Reports Third Quarter 2020 Results
November 16, 2020 |  finance.yahoo.com
MediPharm inks medical cannabis supply deal with STADA
October 5, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Phone705 719 7425
Year FoundedN/A



Sales & Book Value

Annual SalesC$62.40 million
Cash FlowC$0.22 per share
Book ValueC$0.76 per share



Market CapC$67.70 million
Next Earnings Date3/25/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.35 out of 5 stars

Analyst Opinion: 3.1Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.01 (-2.02 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LABS News and Ratings via Email

Sign-up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MediPharm Labs Corp. (LABS.TO) (TSE:LABS) Frequently Asked Questions

Is MediPharm Labs Corp. (LABS.TO) a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs Corp. (LABS.TO) in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MediPharm Labs Corp. (LABS.TO) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LABS, but not buy additional shares or sell existing shares.
View analyst ratings for MediPharm Labs Corp. (LABS.TO)
or view top-rated stocks.

What stocks does MarketBeat like better than MediPharm Labs Corp. (LABS.TO)?

Wall Street analysts have given MediPharm Labs Corp. (LABS.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MediPharm Labs Corp. (LABS.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is MediPharm Labs Corp. (LABS.TO)'s next earnings date?

MediPharm Labs Corp. (LABS.TO) is scheduled to release its next quarterly earnings announcement on Thursday, March 25th 2021.
View our earnings forecast for MediPharm Labs Corp. (LABS.TO)

How has MediPharm Labs Corp. (LABS.TO)'s stock price been impacted by COVID-19 (Coronavirus)?

MediPharm Labs Corp. (LABS.TO)'s stock was trading at C$1.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LABS stock has decreased by 73.6% and is now trading at C$0.49.
View which stocks have been most impacted by COVID-19

What price target have analysts set for LABS?

4 brokers have issued 12 month price objectives for MediPharm Labs Corp. (LABS.TO)'s stock. Their forecasts range from C$1.25 to C$2.50. On average, they expect MediPharm Labs Corp. (LABS.TO)'s share price to reach C$1.98 in the next year. This suggests a possible upside of 308.2% from the stock's current price.
View analysts' price targets for MediPharm Labs Corp. (LABS.TO)
or view top-rated stocks among Wall Street analysts.

Who are MediPharm Labs Corp. (LABS.TO)'s key executives?

MediPharm Labs Corp. (LABS.TO)'s management team includes the following people:
  • Mr. Patrick McCutcheon, Founder & Chairman
  • Mr. Keith Strachan, Co-Founder, Interim CEO & Director
  • Ms. Olga Utkutug, Interim Chief Financial Officer
  • Ms. Laura Lepore, VP of Investor Relations & Communications
  • Mr. Ahmed Shehata, Gen. Counsel & Head of Corp. Devel.
  • Mr. Brett Moon, VP of Sales
  • Ms. Lorna Willner, Director of HR
  • Mr. Warren Everitt, CEO of Asia Pacific & Director
  • Mr. Kirk Binns, Exec. VP of Global Accounts
  • Mr. Nigel Dewsbury, Head of Quality

Who are some of MediPharm Labs Corp. (LABS.TO)'s key competitors?

What other stocks do shareholders of MediPharm Labs Corp. (LABS.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs Corp. (LABS.TO) investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International, Inc. (VFF.TO) (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO Corp. (HEXO.TO) (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST).

What is MediPharm Labs Corp. (LABS.TO)'s stock symbol?

MediPharm Labs Corp. (LABS.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS."

How do I buy shares of MediPharm Labs Corp. (LABS.TO)?

Shares of LABS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is MediPharm Labs Corp. (LABS.TO)'s stock price today?

One share of LABS stock can currently be purchased for approximately C$0.49.

How much money does MediPharm Labs Corp. (LABS.TO) make?

MediPharm Labs Corp. (LABS.TO) has a market capitalization of C$67.70 million and generates C$62.40 million in revenue each year.

How many employees does MediPharm Labs Corp. (LABS.TO) have?

MediPharm Labs Corp. (LABS.TO) employs 230 workers across the globe.

What is MediPharm Labs Corp. (LABS.TO)'s official website?

The official website for MediPharm Labs Corp. (LABS.TO) is www.medipharmlabs.com.

How can I contact MediPharm Labs Corp. (LABS.TO)?

The company can be reached via phone at 705 719 7425.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.